{"id":"946394317378-56","name":"Emergent BioSolutions","registrationDate":"2015-05-15T14:32:00.981+01:00","category":2,"subCategory":3,"legal":"Inc.","web":"http://emergentbiosolutions.com/","country":"United states","headAddress":"1455, Pennsylvania Avenue, N.W.","headCity":"Washington D.C.","headPostCode":"20004","headPhone":"(1)24 06 31 33 98","boss":"Chris Frech","bossTitle":"Mr","bossPosition":"Senior Vice President Government Affairs","membersCount":9,"membersFTE":"2.25","membership":"","memberOrga":"","goal":"As a global specialty pharmaceutical company, Emergent offers specialised products to healthcare providers and governments to address medical needs and emerging health threats.","acronym":"","interests":"Borders and Security, External Relations, Foreign affairs and security policy, Humanitarian aid and civil protection, Institutional affairs, Public Health, Research and innovation","euInitiatives":"Emergent develops specialised products and medical countermeasures for healthcare professionals and governments to protect nations against CBRN threats. &#xd;<br />&#xd;<br />Areas of EU focus: Public health, cross-border health threats, security, medicinal products for human use, internal security, crisis management, counter-terrorism, EU CBRN Action Plan.","lastUp":"2019-03-19T13:37:04.443+01:00","customers":"","costAbsolu":"","costRange":"","turnoverAbsolu":0,"turnoverRange":""}